Close
The NIHR Portfolio consists of high-quality clinical research studies across a range of over 26 speciality groups that are eligible for consideration for research support from the Clinical Research Network in England. Portfolio adoption can provide management of current studies, facilitate feasibility of future studies and support with staffing. Activity data of studies and recruitment from the NIHR portfolio is used to inform NHS infrastructure allocation and supports the performance management of each of the Clinical Research Networks. The QSCTC encourages researchers to adopt their studies onto the NIHR portfolio providing that they meet the eligibility criteria. Divisional Portfolio Officers are available as a single point of contact to guide research through the adoption process, help with study feasibility and manage performance. The Portfolio officer working with the QSCTC is Amal Qureshi (amal.qureshi@qmul.ac.uk).
Benefits of Portfolio adoption:
- Access to a local network of research support staff such as research nurses and other healthcare professionals
- Offering support to ensure research studies are feasible to be carried out under the NHS
- Providing access to staff that can carry out local governance checks and obtain NHS permission
- Managing study performance by monitoring Key Performance Indicators such as time to target recruitment in studies
To access more information on eligibility, when and how to apply open the following links:
Eligibility Criteria
Research studies funded by the NIHR and NIHR Partners are automatically eligible for portfolio adoption. Otherwise, studies need to have a source of funding from open competition. Also, the research being carried out has to be of value to the NHS and needs to be feasible within the realities of the NHS.
When to apply
As long as your research study meets the eligibility criteria, it is important to apply for portfolio adoption at an early stage (i.e. before completion of the R&D form and SSI form). This gives enough time for the research study to be processed through the Coordinated System for gaining NHS Permission (CSP) system for R&D (NHS) approval and potential funding being received from the network.
How to apply
When completing the IRAS form, Question 5b states ‘Do you want your NHS R&D application to be processed through the NIHR Coordinated System for gaining NHS Permission’ –for this select Yes. This will then generate a portfolio adoption form (PAF) through IRAS where North Thames will be the local clinical research network for Queen Square, and you will be notified once your study is adopted onto the NIHR portfolio.
